JS Whelan
- Rheumatology top 5%
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 3
- Chemotherapy-induced organ toxicity mitigation 1
-
- Sarcoma Diagnosis and Treatment 6
- Gastroenterology top 10%
- Neurology top 10%
-
- Chronic Lymphocytic Leukemia Research 2
- Virus-based gene therapy research 1
-
- Vascular Tumors and Angiosarcomas 1
- Cancer Risks and Factors 1
-
- DNA Repair Mechanisms 1
- Co-authors
- Jim JaninisL. ViniGerasimos AravantinosPaolo G. CasaliJean‐Yves BlayR L SouhamiRussell BurcombeAnna Maria Baldelli
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
JS Whelan
13 papers receiving 545 citations
Peers
Comparison fields: 5 of 56
- Rheumatology 244
- Pathology and Forensic Medicine 189
- Pulmonary and Respiratory Medicine 319
- Gastroenterology 46
- Neurology 110
Countries citing papers authored by JS Whelan
This map shows the geographic impact of JS Whelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JS Whelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JS Whelan more than expected).
Fields of papers citing papers by JS Whelan
This network shows the impact of papers produced by JS Whelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JS Whelan. The network helps show where JS Whelan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside JS Whelan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | Controversies in childhood osteosarcoma. | 2013 | 21 |
| 3 | Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. ESMO/CONTICANET/EUROBONET Consensus Panel of Experts. | 2010 | 72 |
| 4 | The more it hurts, the better it works? Chemotherapy toxicity as a predictor of outcome from osteosarcoma: a report from the European Osteosarcoma Intergroup. | 2008 | 1 |
| 5 | Current Management of Osteosarcoma. | 2006 | 0 |
| 6 | High-dose ifosfamide in relapsed or progressive Ewing's sarcoma. | 2005 | 2 |
| 7 | 2003 | 220 | |
| 8 | The incidence of cancer in adolescents and young adults in South East England. An analysis of Thames Cancer Registry Data 1998-2000 | 2003 | 9 |
| 9 | 2002 | 61 | |
| 10 | Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay. | 1999 | 80 |
| 11 | 1997 | 65 | |
| 12 | 1992 | 27 | |
| 13 | 1992 | 2 | |
| 14 | VAPEC B: a weekly chemotherapy for high grade non-Hodgkin's lymphoma. Early results of a collaborative trial at two centres. | 1990 | 1 |
About JS Whelan
JS Whelan is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 14 papers that have together received 562 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Vascular Tumors and Angiosarcomas (1 paper), Virus-based gene therapy research (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper), DNA Repair Mechanisms (1 paper) and Cancer Risks and Factors (1 paper). The work is most often cited by research in Rheumatology (244 citations), Pathology and Forensic Medicine (189 citations) and Pulmonary and Respiratory Medicine (319 citations). JS Whelan has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Jim Janinis, L. Vini, Gerasimos Aravantinos, Paolo G. Casali, Jean‐Yves Blay, R L Souhami, Russell Burcombe, Anna Maria Baldelli, A.M. Cassoni and John A. Hartley. Their work appears in journals such as Blood, Annals of Oncology, Bone Marrow Transplantation, PubMed and UCL Discovery (University College London).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.